Special meeting soon to decide action on online drug sales

PUTRAJAYA: A special meeting will be convened soon to discuss measures to curb the online sale of illicit substances, including drug-laced vape liquids.
MADANI Government spokesperson and Communications Minister Datuk Fahmi Fadzil said the meeting will involve his ministry, the Ministry of Health (MOH), and the Ministry of Domestic Trade and Cost of Living (KPDN).
He said the outcome of the meeting would be presented to the Cabinet for further action, including enforcement against individuals selling illicit substances and the online platforms enabling such sales.
'This includes the sale of vape liquids believed to contain prohibited drugs via mobile applications and online platforms,' he added.
'This reflects the Cabinet's and the government's deep concern over the growing issue of prohibited products being widely sold online,' he said in a post-Cabinet meeting press conference today.
Recently, public concern has been mounting over the presence of synthetic substances or drugs in vapes and e-cigarettes sold online.
Several cases have also emerged linking the deaths of students to psychoactive substances, such as 'magic mushrooms', found in vape liquids.
On June 5, Fahmi reportedly said that the Malaysian Communications and Multimedia Commission (MCMC) had been instructed to monitor the sale of prohibited substances allegedly conducted via several social media platforms.
Meanwhile, the MOH has set up a special committee to review existing legislation under the Control of Smoking Products for Public Health Act 2024 to address the issue.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Rakyat Post

6 hours ago

• Rakyat Post

Malaysia Records First COVID-19 Death In 2025

Subscribe to our FREE Malaysia has recorded its first COVID-19-related death of 2025, according to a statement released by the Ministry of Health (MoH) on 19 June. The fatality occurred during Epidemiological Week 24 (8–15 June). The individual, who had serious pre-existing health conditions such as heart disease and diabetes, had not received the second booster dose of the COVID-19 vaccine. MoH noted that this was the first COVID-19 death since 26 May 2024, and a significant drop compared to the 57 COVID-related deaths reported in 2024. COVID-19 Cases on the Rise, But Situation Under Control As of Week 24, Malaysia has reported 21,738 cumulative COVID-19 cases in 2025, with the weekly average hovering around 900 cases. However, MoH did flag a 68% week-on-week spike, with 3,379 cases reported in Week 24 compared to 2,011 the previous week. Despite the increase, the ministry assured that the national COVID-19 situation remains stable and below the national alert threshold. In terms of severe cases, six patients were admitted to the ICU, all with underlying health issues. All have since been discharged from intensive care; four have returned home, while two remain in regular hospital wards for follow-up treatment. New Variant on the Radar: NB.1.8.1 or 'Nimbus' The World Health Organisation (WHO) is closely monitoring the spread of NB.1.8.1, a Photo: Freepik WHO has classified Nimbus as a Variant Under Monitoring (VUM) due to its rapid transmission and potential health risks. Nimbus spreads faster than previous variants. Common symptoms include: razor-blade-like sore throat, fatigue, mild cough, fever, muscle aches and nasal congestion. What You Can Do Health experts continue to urge the public to take precautions, especially as new variants emerge. Wear a high-quality mask in crowded indoor spaces, improve indoor ventilation: open windows, use fans or air purifiers, get tested if you're feeling unwell or exposed to COVID-19, and stay home when sick to reduce the risk of transmission. Photo: Malay Mail While Malaysia's current COVID-19 situation remains under control, this latest death and the emergence of new variants serve as reminders that vigilance and public health measures remain crucial. Share your thoughts with us via TRP's . Get more stories like this to your inbox by signing up for our newsletter.

Free Malaysia Today

7 hours ago

• Free Malaysia Today

Cabinet mulls crackdown on drug-laced vapes on social media

Police said electronic cigarettes and vapes have become increasingly linked to the abuse of new synthetic drugs. PETALING JAYA : Putrajaya is looking to crack down on the sale of banned substances on social media, including drug-laced vape devices, says government spokesman Fahmi Fadzil. At a press conference, Fahmi said the matter was brought up by domestic trade and cost of living minister Armizan Mohd Ali at today's Cabinet meeting. 'The Cabinet was informed today by Armizan regarding the sale of illegal products online, including items that can be classified as drugs or narcotics, and those misused with vape devices,' he said. Fahmi said he will meet Armizan and health minister Dzulkefly Ahmad soon to discuss the implementation of enforcement measures on the issue. 'After our meeting, we will present the outcome to the Cabinet and take action either on those selling the products or the platforms that allow such products to be sold,' said the communications minister. Previously, deputy inspector-general of police Ayob Khan Mydin Pitchay said electronic cigarettes and vapes have become increasingly linked to the abuse of new synthetic drugs. He said students as young as 13 years old have been caught using vapes containing substances mixed with drugs, and urged more states to ban the sale of vapes and e-cigarettes. Ayob also said fentanyl has also been detected in vape liquids, with effects 100 times stronger and more dangerous than morphine and 20 to 40 times stronger than heroin.

The Star

12 hours ago

• The Star

S'poreans can test for genetic condition causing high cholesterol levels under new programme

The new genetic testing programme for familial hypercholesterolaemia comes amid broader efforts to enhance preventive care in Singapore. - AFP SINGAPORE: Eligible Singapore residents will be able to screen for a genetic condition which causes high cholesterol levels at a subsidised rate as part of a nationwide programme launching on June 30. In a statement on June 19, the Ministry of Health (MOH) said that the new genetic testing programme for familial hypercholesterolaemia (FH) comes amid broader efforts to enhance preventive care in Singapore. The initiative aims to identify individuals with FH early and reduce the risk of premature heart disease with timely interventions. FH is a hereditary condition that impacts the body's ability to process cholesterol, affecting roughly 20,000 people in Singapore. People with the condition are up to 20 times more likely to experience heart attacks at a younger age compared with the general population. In a Facebook post on June 19, Health Minister Ong Ye Kung said that the Government is looking to expand preventive care based on genetic testing to more diseases beyond FH. 'It is part of our longer term effort to develop predictive preventive care under Healthier SG,' he said. As part of this effort, the ministry aims to open three genomic assessment centres (GACs) to ensure effective, efficient and sustainable delivery of genetic testing services within each healthcare cluster. Genetics testing for FH at these centres will be subsidised for eligible Singapore citizens and permanent residents (PRs). They can also tap on MediSave to offset the cost. Those referred to GACs will undergo: Pre-test genetic counselling to understand potential outcomes and benefits before consenting to the test Blood drawing and the genetic test Post-test genetic counselling, to understand the implications of the results The first GAC will be operated by SingHealth and located at the National Heart Centre. It will start accepting referrals from June 30. This centre will serve all Singapore residents until additional centres open. GACs operated by National Healthcare Group and National University Health System will subsequently open to cater to residents' needs. Immediate family members of those found with the condition are at risk and encouraged to undergo genetic testing, MOH said. Known as cascade screening, this process enables early detection of FH within families. It also allows for more timely intervention and treatment, such as advising them to adopt healthier lifestyles or starting on cholesterol-lowering therapies. Under the programme, Singapore citizens and PRs with abnormally high cholesterol levels may be referred by their doctors for genetic testing. Eligible Singaporeans and PRs can receive subsidies of up to 70 per cent for the costs, which include the genetic tests, pre-test and post-test counselling, and phlebotomy services. Seniors from the Pioneer Generation and Merdeka Generation are also eligible for additional subsidies. After subsidies, referred patients can expect to pay between US$117 (US$91.06) and US$575. Those eligible for cascade screening can expect to pay between US$53 and US$253 after subsidies. The MediSave500 and MediSave700 scheme can be used to further offset the cost of the genetic test after subsidies. Patients who are 60 years old and above may also use Flexi-MediSave to further defray out-of-pocket costs. Under a moratorium on genetic testing and insurance introduced by MOH and the Life Insurance Association Singapore (LIA) in 2021, life insurers here are banned from using predictive genetic test results in assessing the outcome of insurance applications, unless certain criteria are satisfied. Insurers are also not allowed to use genetic test results from biomedical research or direct-to-consumer genetic test results. MOH said it has worked with the LIA to amend the moratorium to disallow life insurers in Singapore to use the results of all genetic tests conducted under the national FH genetic testing programme. They may, however, continue to request for individuals to disclose existing diagnosed conditions and family history. The amended moratorium will take effect from June 30. - The Straits Times/ANN